Antimicrobial Resistance Of Klebsiella Pneumoniae : Mechanisms And Clinical Impact And Developments

1641 Words Dec 17th, 2015 7 Pages
Antimicrobial Resistance in Klebsiella pneumoniae:
Mechanisms and Clinical Impact and Developments

Ryan Cain
BIOM 250
Professor Heinzinger
November 27, 2015 Antimicrobial Resistance in Klebsiella pneumoniae:
Mechanisms and Clinical Impact and Developments Antimicrobial resistance is a growing problem in modern healthcare around the world. Multidrug resistant (MDR) strains of pathogenic bacteria, which are quickly becoming more common, pose a serious risk to patients. One of the most common species of bacteria that cause problems in healthcare today is Klebsiella pneumoniae. Today K. pneumoniae can be responsible for community acquired infections, but is most commonly observed as a major cause of hospital acquired infections which can be fatal. K. pneumoniae has been observed to develop resistance to antibiotics more easily than most bacteria through the production of new enzymes to break them down. As new resistance mechanisms develop, fewer and fewer treatments are available for infections by K. pneumoniae. Although some treatments still remain, few new ones are being explored, thus the best option is to control the development and spread of antimicrobial resistance.
Cellular Characteristics K. pneumoniae is a gammaproteobacterium and part of the family Enterobacteriaceae. They are facultatively anaerobic gram-negative rods that are usually encapsulated and non-motile. They are indole and ornithine decarboxylase negative, ferment lactose, and have a…
Open Document